Sustainability | June 11, 2024
Schneider Electric launches EcoStruxure for life science segment
Accelerating sustainability in Indian pharma industry
Accelerating sustainability in Indian pharma industry
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Oligonucleotides are a unique modality with potential to address hard-to-treat diseases with high unmet need
Merck shared updates on the company’s oncology pipeline and focused R&D approach
The Indian pharmaceutical industry is projected to reach US$ 130 billion by 2030
Bemdaneprocel is the most clinically advanced investigational cell therapy in the U.S. for treating patients living with Parkinson’s disease
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
Greg was also central to the planning, design, and construction of this facility
Bluecrux's digital supply chain twin technology, Axon, plays a critical role in Sanofi's digital supply chain transformation.
Through its rare kidney disease portfolio, Novartis is committed to exploring a range of treatment options with different modes of action to slow IgAN progression
Subscribe To Our Newsletter & Stay Updated
